Neverland Project
| Reference number | |
| Coordinator | Igeia Health Labs AB |
| Funding from Vinnova | SEK 300 000 |
| Project duration | November 2018 - February 2019 |
| Status | Completed |
Important results from the project
The purpose and goal of the project has been to make our concept ready for the market. We have done this but new challenges have arisen. This is quite natural given the complexity of the project. And we are close to being able to release our first generation concept.
Expected long term effects
We have received feedback from a number of users and clients. This feedback has been the basis for developing the concept in order to be able to go to market. As part of this work, we have also made relevant budget estimates and developed a pricing strategy. Within the framework of the project, we have also developed a patent application that was submitted in 2018.
Approach and implementation
We have conducted a number of interviews with potential customers and end users. These interviews have been the basis for the project´s development. From our perspective, the project has been very successful. We are considerably closer to a market launch than we were before the start of the project.